Our Firm
Our team of experts have in-depth knowledge of the drug industry with experience in numerous drug classes. Collectively our experience extends to hundreds of INDs and dozens of drug approvals. We offer our clients only consultants who are experts in their respective fields, with a proven track record. We give you the flexibility to use our experienced consultants as your entire virtual team, or select consultants to augment your existing team as needed. As an independent consulting organization, we have long and established relationships with the best service providers in various disciplines which allow clients the ability to efficiently navigate the drug development process.
Principal Founders
Brian C. Rogers, Ph.D., D.A.B.T., M.B.A.
Brian is a co-founder of the company and has nearly 30 years of industrial toxicology experience including over 25 years in the biotechnology and pharmaceutical industry. During this time he has interacted extensively with the FDA and authored hundreds of INDs and over two dozen NDA and BLA nonclinical sections on behalf of clients. Prior to co-founding Pacific BioDevelopment, Brian was a Scientist/Toxicologist at Genentech and prior to that a Toxicologist/Study Director at Chevron. He holds a Ph.D. in Toxicology from the University of North Carolina, Chapel Hill, NC and a B.S. in Environmental Toxicology, University of California, Davis, CA (UCD). He is a Diplomate of the American Board of Toxicology (since 1993) and also holds an MBA from and was an adjunct professor at the UCD School of Management. He serves as a Business and/or Scientific advisor to several companies, including Senzagen, Inc., a provider of in vitro immunotoxicology services.
Jerome Moore, M.S.
Jerry is a co-founder whose scientific expertise is in the areas of Pharmacology and Pharmacokinetics. He has over 30 years of experience, including Genentech, Celtrix Pharmaceuticals, UC Berkeley, and Stanford University. He has written ADME sections for dozens of INDs and clinical pharmacology and ADME sections for NDAs. His experience enables him to develop and evaluate non-clinical and clinical pharmacokinetics and pharmacology programs for drug development and regulatory submissions. He holds an M.S. in Neurobiology and a B.S. in Microbiology, both from Purdue University, West Lafayette, IN.